Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Abbvie, Amgen Deal on Humira Biosimilars Likely to Cost CMS More Than $1B
Abbvie, Amgen Deal on Humira Biosimilars Likely to Cost CMS More Than $1B
Abbvie, Amgen Deal on Humira Biosimilars Likely to Cost CMS More Than $1B
Submitted by
admin
on October 2, 2017 - 11:18am
Source:
RAPS.org
News Tags:
AbbVie
Amgen
Humira
biosimilars
Medicare
Medicaid
CMS
Headline:
Abbvie, Amgen Deal on Humira Biosimilars Likely to Cost CMS More Than $1B
Do Not Allow Advertisers to Use My Personal information
